Baidu
map

生物制品新分类 细胞治疗按药品注册上市

2017-10-26 仲夏秋夜云 蒲公英

生物制品新分类,细胞治疗按药报!

生物制品新分类,细胞治疗按药报!

谁也没想到,在总局发布了药品注册管理办法征求意见稿之后,各大媒体都进行了解读解读之后,他们居然又挂上了一个压缩包…我相信,所有的媒体当时都没有看到。不然不会有人漏掉那么重大的新闻。



1.生物制品新分类

和花妖一样,生物制品也这么分类了,新药,仿制品主线,进口单独。

2.生物制品有CTD格式了

不仅有了格式,而且把每一部分的要求,哪些东西应该报临床的时候,做完哪些应该报生产的时候做完写得非常详细。

3.治疗用生物制品可以按药报

之前很多公司选择技术手段三类,也有人抱怨,如果按照药品报没有太多的机会和途径。现在明确有了,但是不知道这些企业看到这张资料表会作何感想。按药报就按药的要求来。

4.预防用生物制品这次也在分类里

我们有很多法规,用生物制品都是单独成本的。这次的分类方式,预报用生物制品,也是按此规矩分成了五类。只有一个小毛病,在预防用生物制品的分类里把他写成了治疗用生物制品。



总结一下,让子弹飞一下,重复的刷新几下,会有新的惊喜



版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1440612, encodeId=1d0614406123d, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87444, encryptionId=eeeb8e444e6, topicName=药品注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3f64741524, createdName=1508842480_96220438, createdTime=Sat Oct 28 02:44:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476246, encodeId=f93714e624673, content=<a href='/topic/show?id=ae0669226c3' target=_blank style='color:#2F92EE;'>#生物制品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69226, encryptionId=ae0669226c3, topicName=生物制品)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd657261208, createdName=楚钟, createdTime=Sat Oct 28 02:44:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556783, encodeId=0a441556e83a2, content=<a href='/topic/show?id=e4016495635' target=_blank style='color:#2F92EE;'>#注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64956, encryptionId=e4016495635, topicName=注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c52c14833361, createdName=zhyy93, createdTime=Sat Oct 28 02:44:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256114, encodeId=2229256114da, content=很好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Oct 26 12:24:49 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1440612, encodeId=1d0614406123d, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87444, encryptionId=eeeb8e444e6, topicName=药品注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3f64741524, createdName=1508842480_96220438, createdTime=Sat Oct 28 02:44:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476246, encodeId=f93714e624673, content=<a href='/topic/show?id=ae0669226c3' target=_blank style='color:#2F92EE;'>#生物制品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69226, encryptionId=ae0669226c3, topicName=生物制品)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd657261208, createdName=楚钟, createdTime=Sat Oct 28 02:44:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556783, encodeId=0a441556e83a2, content=<a href='/topic/show?id=e4016495635' target=_blank style='color:#2F92EE;'>#注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64956, encryptionId=e4016495635, topicName=注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c52c14833361, createdName=zhyy93, createdTime=Sat Oct 28 02:44:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256114, encodeId=2229256114da, content=很好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Oct 26 12:24:49 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1440612, encodeId=1d0614406123d, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87444, encryptionId=eeeb8e444e6, topicName=药品注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3f64741524, createdName=1508842480_96220438, createdTime=Sat Oct 28 02:44:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476246, encodeId=f93714e624673, content=<a href='/topic/show?id=ae0669226c3' target=_blank style='color:#2F92EE;'>#生物制品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69226, encryptionId=ae0669226c3, topicName=生物制品)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd657261208, createdName=楚钟, createdTime=Sat Oct 28 02:44:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556783, encodeId=0a441556e83a2, content=<a href='/topic/show?id=e4016495635' target=_blank style='color:#2F92EE;'>#注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64956, encryptionId=e4016495635, topicName=注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c52c14833361, createdName=zhyy93, createdTime=Sat Oct 28 02:44:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256114, encodeId=2229256114da, content=很好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Oct 26 12:24:49 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
    2017-10-28 zhyy93
  4. [GetPortalCommentsPageByObjectIdResponse(id=1440612, encodeId=1d0614406123d, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87444, encryptionId=eeeb8e444e6, topicName=药品注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3f64741524, createdName=1508842480_96220438, createdTime=Sat Oct 28 02:44:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476246, encodeId=f93714e624673, content=<a href='/topic/show?id=ae0669226c3' target=_blank style='color:#2F92EE;'>#生物制品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69226, encryptionId=ae0669226c3, topicName=生物制品)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd657261208, createdName=楚钟, createdTime=Sat Oct 28 02:44:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556783, encodeId=0a441556e83a2, content=<a href='/topic/show?id=e4016495635' target=_blank style='color:#2F92EE;'>#注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64956, encryptionId=e4016495635, topicName=注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c52c14833361, createdName=zhyy93, createdTime=Sat Oct 28 02:44:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256114, encodeId=2229256114da, content=很好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Oct 26 12:24:49 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
    2017-10-26 清风拂面

    很好的文章.学习了

    0

相关资讯

全球CAR-T临床研究项目盘点:4年新增项目数量翻4.5倍

我国的CAR-T研究虽然起步不算早,但从2013年增长迅猛。目前,我国的临床研究项目位于全球第二,仅次于美国。

食药监管总局公布2015年度药品上市批准情况

为进一步提高药品审评审批透明度,有效指导药物研发申报及药品临床应用,食品药品监管总局日前发布公告,公布了《2015年批准上市的中药、天然药物目录》、《2015年批准上市的化学药品目录》、《2015年批准上市的生物制品目录》。   据统计,2015年度食品药品监管总局共批准中药、天然药物上市注册申请76个,化学药品上市注册申请241个,生物制品上市注册申请25个。详细信息请查阅《国

Baidu
map
Baidu
map
Baidu
map